One of my prior posts (http://advancedprostatecancer.net/wp-admin/post.php?post=5349&action=edit) explained the current movement to establish a rating system that a prostate cancer survivor, along with their doctor, could use to make better decisions about which drugs to use. The rating system, or formula, factors in information about efficacy (additional survival time), side effects, safety of the drug, and symptom control.
I have received a number of questions asking me to expand upon the proposed formula. So, here it is:
The efficacy portion of ASCO’s rating accounts for up to 80 points of the score. ASCO also awards up to 20 points based on how safe the drug was relative to the control group during trials. An additional 30 points can be awarded depending on certain other factors, such as symptom control, meaning that the maximum score that can be awarded is 130.